Tumor hypoxia is a common feature of prostate tumors associated with the stabilization of hypoxia-inducible-factor 1alpha (HIF-1α) and poor prognosis following radiation therapy. Lack of oxygen at the time of irradiation is associated with radioresistance, but recent reports suggest radioresponse is also modulated by the dynamic nature of tumor hypoxia.
Derek Hennessey, Lynn Martin, Anne Atzberger, Thomas Lynch, Donal Hollywood and Laure Marignol
Download Paper
XBeam V2: FDA-Approved Treatment Planning Software
The Fastest, Safest Way to Plan Superficial & Orthovoltage Treatment XBeam V2 is the revolutionary, FDA 510(k)-cleared dose planning software designed to automate planning, eliminate risk, and seamlessly integrates with the Concerto system, Xstrahl’s clinical...
